Exact Sciences, which has for years sold a stool-based colon cancer test, on Monday announced that a blood-based test it’s developing showed promise in accurately detecting the disease. In a study of more than 3,000 samples, the company reported that its test detected 88.3% of cancers and...
“The first generation of blood tests are a really exciting development in the colorectal cancer screening paradigm,” said Uri Ladabaum, MD, a professor of gastroenterology and the first author of the paper, to be published today (October 28) in Annals of Internal Medicine.“But for ...
This image provided by Guardant Health in March 2024, shows packaging for their colon cancer blood test, Shield. According to a study published Wednesday, March 13, 2024, in theNew England Journal of Medicineand sponsored by Guardant Health, the test performed well, further expanding screening op...
The Food and Drug Administration approved a blood test intended to detectcolorectal canceron Monday, expanding options forscreeningfor the potentially deadly disease. The blood test, called Shield, from company Guardant Health, Inc., is approved for screening adults age 45 and older who are at ave...
The blood test was also able to detect 77% of precancerous lesions, indicating an early-stage disease. While these early results appear promising, the sensitivity of the test is still not optimal. The number of patients in the study is also relatively small. Therefore, the test is not ...
However, it was less sensitive for detecting advanced precancerous lesions. The researchers believe that this blood test could improve screening rates and potentially reduce colon cancer deaths.Fillon, MikeCA: A Cancer Journal for Clinicians
Evaluation of an immunochemical fecal occult blood test with automated reading in screening for colorectal cancer in a general average-risk population (p49... Colorectal cancer screening is a high public health priority in all industrialized countries. However, the low sensitivity of the common guaiac...
U.S. health regulators have approved a blood test for colon cancer, offering a new way of screening for a leading cause of cancer deaths.
death rates (mortality) from colorectal cancer by 30-40%. If no colonic abnormalities are found in an individual whose stool contains occult blood, consideration then is given to examining the stomach and the small intestine as sources of bleeding....
A simple home screening test for colon cancer can reduce the risk of dying from the disease by 33%, a new study shows.